| Aktsiad | 558,639 mld. | - | KoAct | 0 | Tervishoid | | 3.8.2023 | 22 584,93 | 14,94 | 37,04 |
| Aktsiad | 300,375 mld. | - | Tiger ETF | 0,40 | Tervishoid | KRX Bio K-New Deal Index - KRW - Benchmark TR Gross | 6.10.2020 | 9436,39 | 6,01 | 68,22 |
| Aktsiad | 283,045 mld. | - | KODEX | 0,45 | Tervishoid | FnGuide Bio Index - Benchmark TR Gross | 13.5.2016 | 12 121,61 | 6,58 | 37,93 |
| Aktsiad | 226,289 mld. | - | Tiger ETF | 0,40 | Tervishoid | KRX Healthcare - KRW | 15.7.2011 | 49 648,17 | 5,26 | 47,17 |
| Aktsiad | 109,544 mld. | - | Tiger ETF | 0,30 | Tervishoid | NASDAQ Biotechnology Index | 26.8.2014 | 31 168,99 | 5,29 | 22,88 |
| Aktsiad | 105,142 mld. | - | KODEX | 0,09 | Tervishoid | KRX Healthcare - KRW | 28.3.2017 | 22 476,74 | 5,26 | 47,16 |
| Aktsiad | 74,656 mld. | - | Tiger ETF | 0,49 | Tervishoid | Solactive China Biotech Index | 3.12.2020 | 9411,48 | 4,50 | 40,71 |
| Aktsiad | 65,925 mld. | - | KODEX | 0,25 | Tervishoid | S&P Health Care Select Sector | 21.3.2023 | 14 050,81 | 5,27 | 23,55 |
| Aktsiad | 63,787 mld. | - | KODEX | 0,45 | Tervishoid | iSelect Global Obesity Treatment TOP2 Plus Index - KRW - Benchmark TR Net | 14.2.2024 | 12 181,35 | 6,65 | 18,07 |
| Aktsiad | 61,14 mld. | - | Tiger ETF | 0,40 | Tervishoid | KOSDAQ 150 Biotech Index - KRW - Benchmark TR Gross | 14.12.2016 | 17 761,74 | 11,22 | 59,10 |
| Aktsiad | 61,051 mld. | - | Tiger ETF | 0,45 | Tervishoid | Indxx Global Obesity Treatment Top 2 Plus index - KRW - Benchmark Price Return | 29.2.2024 | 11 230,00 | 11,30 | 23,22 |
| Aktsiad | 41,709 mld. | 13,183 mln. | SPDR | 0,08 | Tervishoid | S&P Health Care Select Sector | 16.12.1998 | 155,73 | 5,22 | 23,44 |
| Aktsiad | 38,319 mld. | - | KB RISE | 0 | Tervishoid | KRX Bio Top 10 Index - KRW - Benchmark TR Gross | 24.12.2024 | 14 858,90 | 9,56 | 68,04 |
| Aktsiad | 38,118 mld. | - | Tiger ETF | 0,40 | Tervishoid | KOSPI 200 Health Care Index - KRW | 23.9.2015 | 23 566,07 | 3,40 | 40,87 |
| Aktsiad | 30,91 mld. | - | Tiger ETF | 0 | Tervishoid | S&P Global 1200 Health Care Custom Index - krw - Benchmark TR Gross | 29.6.2016 | 27 058,63 | 0 | 0 |
| Aktsiad | 27,359 mld. | - | Hwabao | 0,60 | Tervishoid | CSI Medical Index Yield - Benchmark TR Gross | 20.5.2019 | 0,39 | 3,06 | 30,88 |
| Aktsiad | 20,654 mld. | - | KODEX | 0,25 | Tervishoid | S&P Biotechnology Select Industry | 31.10.2013 | 39 900,06 | 0 | 0 |
| Aktsiad | 17,913 mld. | - | KoAct | 0,50 | Tervishoid | | 11.11.2025 | 10 661,40 | 6,52 | 0 |
| Aktsiad | 17,582 mld. | 278 883,7 | Vanguard | 0,09 | Tervishoid | MSCI US IMI 25/50 Health Care | 26.1.2004 | 289,71 | 5,06 | 23,66 |
| Aktsiad | 17,305 mld. | - | E Fund | 0 | Tervishoid | CSI 300 Medical and Health Index - CNY - Benchmark TR Gross | 9.1.2021 | 0,40 | 3,37 | 26,68 |
| Aktsiad | 16,585 mld. | - | NH-Amundi | 0 | Tervishoid | | 26.11.2024 | 16 130,28 | 6,13 | 40,96 |
| Aktsiad | 10,37 mld. | - | KB RISE | 0 | Tervishoid | FnGuide HealthCare Index - KRW - Benchmark TR Net | 23.9.2016 | 17 356,88 | 5,22 | 43,01 |
| Aktsiad | 9,418 mld. | - | ACE | 0,45 | Tervishoid | Solactive Eli Lilly Value Chain Index - Benchmark Price Return | 19.11.2024 | 13 301,69 | 0 | 0 |
| Aktsiad | 9,218 mld. | - | Tiger ETF | 0,50 | Tervishoid | FnGuide Medical Device Index - KRX - Benchmark TR Net | 7.11.2018 | 18 374,56 | 2,88 | 20,82 |
| Aktsiad | 8,939 mld. | - | ACE | 0,30 | Tervishoid | Solactive Global Big Pharma Index - Benchmark Price Return | 19.11.2024 | 12 586,76 | 0 | 0 |
| Aktsiad | 8,764 mld. | - | Kiwoom | 0,49 | Tervishoid | FnGuide Medical AI Index - KRW - Benchmark TR Gross | 28.5.2024 | 13 416,11 | 0 | 0 |
| Aktsiad | 8,547 mld. | - | KoAct | 0,50 | Tervishoid | | 3.9.2024 | 12 201,95 | 4,44 | 19,05 |
| Aktsiad | 8,526 mld. | 2,024 mln. | iShares | 0,44 | Tervishoid | NYSE Biotechnology (TR) | 5.2.2001 | 169,98 | 5,49 | 23,95 |
| Aktsiad | 8,275 mld. | 9,836 mln. | SPDR | 0,35 | Tervishoid | S&P Biotechnology Select Industry | 31.1.2006 | 124,24 | 5,06 | 0 |
| Aktsiad | 7,345 mld. | - | ChinaAMC | 0,65 | Tervishoid | Hang Seng Biotech Index - HKD - Benchmark TR Net | 29.9.2021 | 0,88 | 3,00 | 21,32 |
| Aktsiad | 6,851 mld. | - | Bosera | 0,65 | Tervishoid | Hang Seng Healthcare Index - CNY - Benchmark TR Gross | 18.3.2021 | 0,68 | 2,75 | 12,80 |
| Aktsiad | 6,42 mld. | - | Maxwealth | 0,60 | Tervishoid | CSI All-Medical Device Index - CNY - Benchmark TR Gross | 22.4.2021 | 0,54 | 2,65 | 31,19 |
| Aktsiad | 5,945 mld. | - | KB RISE | 0,35 | Tervishoid | KEDI Global Obesity Care Industry Top2+ Index - KRW - Benchmark TR Net | 27.2.2024 | 10 756,26 | 9,54 | 21,84 |
| Aktsiad | 5,775 mld. | - | Invesco | 0 | Tervishoid | CSI Hong Kong Stock Connect Innovative Drug Index - CNY - Benchmark TR Net | 16.10.2024 | 1,78 | 3,45 | 24,61 |
| Aktsiad | 5,758 mld. | - | Kiwoom | 0,49 | Tervishoid | Solactive Blockbuster Biotech Drugs Index - CNY - Benchmark TR Net | 28.5.2024 | 11 388,39 | 4,68 | 18,24 |
| Aktsiad | 5,441 mld. | - | Nippon | 0,19 | Tervishoid | Nifty Pharma Index - INR - Benchmark TR Gross | 2.7.2021 | 17,49 | 4,79 | 32,64 |
| Aktsiad | 5,285 mld. | - | NEXT FUNDS | 0,32 | Tervishoid | | 21.3.2008 | 30 893,37 | 1,87 | 24,41 |
| Aktsiad | 4,915 mld. | - | Tiger ETF | 0,40 | Tervishoid | TOPIX-17 PHARMACEUTICAL - JPY | 29.6.2016 | 12 065,00 | 0 | 0 |
| Aktsiad | 4,798 mld. | - | ICBC | 0 | Tervishoid | CSI Hong Kong Stock Connect Innovative Drug Index - CNY - Benchmark TR Net | 26.3.2025 | 1,26 | 0 | 0 |
| Aktsiad | 4,74 mld. | 175 016,9 | iShares | 0,40 | Tervishoid | S&P Global 1200 / Health Care -SEC | 13.11.2001 | 98,79 | 4,68 | 22,83 |
| Aktsiad | 4,382 mld. | - | E Fund | 0 | Tervishoid | CSI Hong Kong Stock Connect Innovative Drug Index - CNY - Benchmark TR Net | 18.3.2025 | 1,40 | 0 | 0 |
| Aktsiad | 4,076 mld. | 1,21 mln. | iShares | 0,38 | Tervishoid | DJ US Select / Medical Equipment | 1.5.2006 | 61,84 | 4,58 | 29,25 |
| Aktsiad | 3,776 mld. | - | Xtrackers | 0,25 | Tervishoid | MSCI World Index / Health Care -SEC | 22.11.2010 | 59,47 | 4,86 | 23,09 |
| Aktsiad | 3,6 mld. | - | Fullgoal | 0,60 | Tervishoid | Hang Seng Hong Kong Stock Connect Healthcare Index - CNY - Chinese Renminbi - Benchmark TR Gross | 14.6.2023 | 1,51 | 0 | 0 |
| Aktsiad | 3,571 mld. | 625 053,2 | iShares | 0,38 | Tervishoid | Russell 1000 Health Care RIC 22.5/45 Capped Index | 12.6.2000 | 65,46 | 5,23 | 23,55 |
| Aktsiad | 3,529 mld. | - | Guotai | 0,60 | Tervishoid | CSI Biomedical Index - CNY - Benchmark TR Gross | 18.4.2019 | 1,08 | 0 | 0 |
| Aktsiad | 3,463 mld. | - | ChinaAMC | 0,75 | Tervishoid | Hang Seng Biotech Index - HKD - Benchmark TR Net | 18.3.2021 | 16,54 | 3,29 | 26,50 |
| Aktsiad | 3,463 mld. | - | ChinaAMC | 0,75 | Tervishoid | Hang Seng Biotech Index - HKD - Benchmark TR Net | 18.3.2021 | 16,54 | 3,29 | 26,50 |
| Aktsiad | 2,874 mld. | 163 574,4 | Fidelity | 0,08 | Tervishoid | MSCI US IMI 25/50 Health Care | 21.10.2013 | 74,76 | 5,14 | 23,74 |
| Aktsiad | 2,773 mld. | - | iShares | 0,15 | Tervishoid | S&P 500 CAPPED 35/20 HEALTH CARE NTR | 20.11.2015 | 12,47 | 5,27 | 23,67 |
| Aktsiad | 2,735 mld. | - | NH-Amundi | 0,45 | Tervishoid | iSelect K-MediTech Index - KRW - Benchmark Price Return | 21.12.2023 | 9115,65 | 3,43 | 26,31 |
| Aktsiad | 2,288 mld. | - | Hwabao | 0 | Tervishoid | Hang Seng SCHK Innovative Drug Select Index - HKD - Benchmark TR Gross | - | 4,09 mld. | 0 | 0 |
| Aktsiad | 2,192 mld. | - | Guotai | 0,60 | Tervishoid | CSI Medical Index Yield - Benchmark TR Gross | 24.12.2020 | 0,48 | 3,06 | 30,91 |
| Aktsiad | 2,047 mld. | - | E Fund | 0,20 | Tervishoid | Yield of China Securities Hong Kong Stock Connect Medical and Health Composite Index - CNY - Benchmark TR Net | 19.1.2022 | 1,21 | 2,50 | 20,25 |
| Aktsiad | 1,749 mld. | - | Ping An | 0,60 | Tervishoid | CSI Pharmaceutical and Medical Device Innovation Index - CNY - Benchmark TR Gross | 9.6.2021 | 0,38 | 4,10 | 25,08 |
| Aktsiad | 1,643 mld. | - | Harvest ETFs | 1,06 | Tervishoid | | 19.11.2014 | 7,83 | 4,93 | 21,81 |
| Aktsiad | 1,545 mld. | - | Cathay | 1,05 | Tervishoid | Solactive Global Genomics Immunology and Medical Revolution Index - Benchmark TR Net | 22.11.2021 | 8,29 | 3,49 | 18,91 |
| Aktsiad | 1,504 mld. | - | iShares | 0,18 | Tervishoid | MSCI Europe Health Care 20/35 Capped Index - EUR | 17.11.2020 | 7,44 | 4,20 | 20,89 |
| Aktsiad | 1,49 mld. | - | Amundi | 0,50 | Tervishoid | MSCI World IMI Virology Select Index - KRW - Benchmark TR Net | 8.6.2022 | 9937,75 | 2,82 | 14,76 |
| Aktsiad | 1,48 mld. | - | iShares | 0,46 | Tervishoid | S&P Global 1200 Healthcare Sector Index - AUD | 13.11.2001 | 147,01 | 0 | 0 |
| Aktsiad | 1,4 mld. | - | E Fund | 0,20 | Tervishoid | CSI Biotechnology Theme Index - CNY - Benchmark TR Gross | 14.1.2021 | 0,54 | 2,78 | 29,20 |
| Aktsiad | 1,373 mld. | - | E Fund | 0,20 | Tervishoid | China Securities Medical Index - CNY - Benchmark TR Gross | 8.7.2021 | 0,45 | 4,33 | 29,55 |
| Aktsiad | 1,371 mld. | 26 939 | First Trust | 0,54 | Tervishoid | NYSE Arca Biotechnology Index | 19.6.2006 | 211,33 | 3,95 | 25,26 |
| Aktsiad | 1,207 mld. | 401 828,9 | VanEck | 0,36 | Tervishoid | MVIS US Listed Pharmaceutical 25 | 20.12.2011 | 105,29 | 5,10 | 19,76 |
| Aktsiad | 1,155 mld. | - | Harvest | 0,60 | Tervishoid | CSI Hong Kong Stock Connect Innovative Drug Index - CNY - Benchmark TR Net | 30.7.2025 | 0,96 | 0 | 0 |
| Aktsiad | 1,14 mld. | - | E Fund | 0,20 | Tervishoid | CSI Innovative Drug Industry Index - CNY - Benchmark TR Gross | 3.2.2021 | 0,70 | 3,12 | 28,62 |
| Aktsiad | 1,097 mld. | - | iShares | 0,40 | Tervishoid | STOXX Global Breakthrough Healthcare (USD)(NR) | 8.9.2016 | 9,36 | 4,28 | 23,65 |
| Aktsiad | 1,097 mld. | - | iShares | 0,40 | Tervishoid | STOXX Global Breakthrough Healthcare (USD)(NR) | 8.9.2016 | 9,36 | 4,28 | 23,65 |
| Aktsiad | 1,017 mld. | - | Wanjia | 0 | Tervishoid | CSI Hong Kong Stock Connect Innovative Drug Index - CNY - Benchmark TR Net | 13.9.2024 | 1,71 | 3,45 | 24,61 |
| Aktsiad | 988,11 mln. | - | Global X | 0,59 | Tervishoid | FactSet Japan Bio & Med Technologies Index - JPY - Benchmark TR Net | 21.6.2021 | 1729,14 | 2,32 | 22,77 |
| Aktsiad | 985,392 mln. | - | Amundi | 0,30 | Tervishoid | STOXX Europe 600 / Health Care (Capped) - SS | 17.1.2019 | 157,38 | 3,71 | 20,97 |
| Aktsiad | 985,392 mln. | - | Amundi | 0,30 | Tervishoid | STOXX Europe 600 / Health Care (Capped) - SS | 17.1.2019 | 157,38 | 3,71 | 20,97 |
| Aktsiad | 974,533 mln. | - | CSOP | 1,50 | Tervishoid | Hang Seng Biotech Index - HKD - Benchmark TR Net | 21.7.2021 | 3,96 | 3,67 | 29,48 |
| Aktsiad | 971,66 mln. | 123 346,3 | iShares | 0,38 | Tervishoid | DJ US Select / Pharmaceutical | 1.5.2006 | 85,67 | 4,49 | 22,43 |
| Aktsiad | 969,371 mln. | - | Xtrackers | 0,12 | Tervishoid | MSCI USA / Health Care -SEC | 12.9.2017 | 63,54 | 5,45 | 23,73 |
| Aktsiad | 969,371 mln. | - | Xtrackers | 0,12 | Tervishoid | MSCI USA / Health Care -SEC | 12.9.2017 | 63,54 | 5,45 | 23,73 |
| Aktsiad | 964,508 mln. | 20 606,25 | First Trust | 0,62 | Tervishoid | StrataQuant Health Care Index | 8.5.2007 | 115,75 | 2,90 | 17,24 |
| Aktsiad | 871,637 mln. | - | iShares | 0,35 | Tervishoid | NASDAQ Biotechnology Index | 19.10.2017 | 8,38 | 0 | 0 |
| Aktsiad | 796,573 mln. | - | Amundi | 0,30 | Tervishoid | MSCI World Index / Health Care -SEC | 19.8.2010 | 495,05 | 7,68 | 29,88 |
| Aktsiad | 783,357 mln. | 84 988,43 | Invesco | 0,40 | Tervishoid | S&P 500 Equal Weighted / Health Care -SEC | 1.11.2006 | 32,85 | 3,33 | 21,58 |
| Aktsiad | 767,584 mln. | - | Guotai | 0,60 | Tervishoid | SSE STAR Market Innovative Drug Index - CNY - Benchmark TR Gross | 1.8.2025 | 0,97 | 0 | 0 |
| Aktsiad | 764,986 mln. | 234 038,7 | iShares | 0,38 | Tervishoid | DJ US Select / Health Care Providers | 1.5.2006 | 48,90 | 2,49 | 18,16 |
| Aktsiad | 758,164 mln. | - | iShares | 0,46 | Tervishoid | STOXX Europe 600 / Health Care (Capped) - SS | 25.4.2001 | 119,02 | 4,13 | 21,02 |
| Aktsiad | 701,354 mln. | - | Global X | 0,68 | Tervishoid | Solactive China Biotech Index | 25.7.2019 | 75,92 | 4,64 | 44,26 |
| Aktsiad | 701,354 mln. | - | Global X | 0,68 | Tervishoid | Solactive China Biotech Index | 25.7.2019 | 75,92 | 4,64 | 44,26 |
| Aktsiad | 693,345 mln. | - | Cathay | 0,41 | Tervishoid | Bloomberg Barclays 15+ Year Healthcare Select Index - Benchmark TR Net | 23.4.2019 | 30,75 | 0 | 0 |
| Aktsiad | 673,401 mln. | - | SPDR | 0,18 | Tervishoid | MSCI Europe Health Care Index - EUR | 5.12.2014 | 236,24 | 4,20 | 20,89 |
| Aktsiad | 653,47 mln. | 697 008,8 | Direxion | 0,93 | Tervishoid | S&P Biotechnology Select Industry | 28.5.2015 | 165,90 | 0 | 0 |
| Aktsiad | 652,47 mln. | - | SPDR | 0,30 | Tervishoid | MSCI World Health Care 35/20 Capped Index - Benchmark TR Net | 29.4.2016 | 68,31 | 5,08 | 25,68 |
| Aktsiad | 608,328 mln. | - | iShares | 0,18 | Tervishoid | MSCI World Health Care ESG Reduced Carbon Select 20 35 Capped Index - Benchmark TR Net | 17.10.2019 | 7,92 | 4,16 | 22,04 |
| Aktsiad | 605,498 mln. | - | ChinaAMC | 0,60 | Tervishoid | CSI All-Medical Device Index - CNY - Benchmark TR Gross | 23.11.2023 | 0,94 | 2,65 | 31,16 |
| Aktsiad | 594,57 mln. | - | iShares | 0,66 | Tervishoid | S&P Global 1200 Health Care Hedged to CAD Index - CAD | 12.4.2011 | 71,61 | 0 | 0 |
| Aktsiad | 579,48 mln. | - | China Southern | 0,65 | Tervishoid | Hang Seng Biotech Index - HKD - Benchmark TR Gross | 17.6.2022 | 1,26 | 2,97 | 21,35 |
| Aktsiad | 574,642 mln. | - | SPDR | 0,15 | Tervishoid | S&P Health Care Select Sector Daily Capped 25/20 Index | 7.7.2015 | 48,11 | 5,22 | 23,44 |
| Aktsiad | 508,65 mln. | - | Fullgoal | 0,60 | Tervishoid | CSI Pharmaceutical 50 Index - CNY - Benchmark TR Gross | 16.3.2020 | 0,98 | 0 | 0 |
| Aktsiad | 473,57 mln. | - | Guotai | 0,60 | Tervishoid | CSI Shanghai-Hong Kong-Shenzhen Innovative Pharmaceutical Industry Index - CNY - Benchmark TR Gross | 8.9.2021 | 0,79 | 3,51 | 27,58 |
| Aktsiad | 431,721 mln. | - | Maxwealth | 0,60 | Tervishoid | CSI Hong Kong Stock Connect Healthcare Index - CNY - Benchmark TR Net | 2.4.2025 | 1,64 | 0 | 0 |
| Aktsiad | 427,641 mln. | - | Invesco | 0,40 | Tervishoid | NASDAQ / Biotechnology | 6.11.2014 | 59,92 | 5,25 | 23,00 |
| Aktsiad | 416,56 mln. | - | Invesco | 0,14 | Tervishoid | S&P Select Sector Capped 20% Health Care Index | 16.12.2009 | 773,71 | 5,10 | 22,93 |
| Aktsiad | 388,686 mln. | 15 459,27 | Invesco | 0,57 | Tervishoid | Dynamic Pharmaceutical Intellidex Index (AMEX) | 23.6.2005 | 103,96 | 2,96 | 18,69 |